• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌患者的乙肝表面抗原血症与临床病程及甲胎蛋白的关系

Hepatitis B surface antigenemia in patients with hepatocellular carcinoma in relation to clinical course and alpha-fetoprotein.

作者信息

Kubo Y, Okuda K, Shimokawa Y, Arishima T, Nagata E

出版信息

Gastroenterology. 1977 Jun;72(6):1213-6.

PMID:67061
Abstract

Hepatitis B surface antigen was determined in sera of 122 cases of hepatocellular carcinoma seen in Japan, using both the counterimmunoelectrophoresis and radioimmunoassay (RIA) techniques. It was positive in 49.2% of the patients with RIA, but the level of antigen in serum was relatively low since positivity rate by counterimmunoelectrophoresis was only 10.7%, The degree of antigenemia as assessed from the count relative to the cut-off value in RIA, was increased during the clinical course in 75% of the patients. The antigen tended to rise in concentration when the tumor grew at a rapid rate, when damage to liver parenchyma was extensive, or in patients receiving chemotherapy. There was also a tendency for less frequent positive antigen tests in patients with higher alpha-fetoprotein levels. Illustrative cases are presented with discussion on the possible explanation for the change in the degree of antigenemia.

摘要

采用对流免疫电泳和放射免疫测定(RIA)技术,对日本122例肝细胞癌患者的血清进行了乙肝表面抗原检测。RIA检测显示49.2%的患者呈阳性,但血清中的抗原水平相对较低,因为对流免疫电泳的阳性率仅为10.7%。根据RIA中相对于临界值的计数评估,75%的患者在临床过程中抗原血症程度增加。当肿瘤快速生长、肝实质损伤广泛或患者接受化疗时,抗原浓度往往会升高。甲胎蛋白水平较高的患者抗原检测呈阳性的频率也有较低的趋势。文中给出了示例病例,并讨论了抗原血症程度变化的可能原因。

相似文献

1
Hepatitis B surface antigenemia in patients with hepatocellular carcinoma in relation to clinical course and alpha-fetoprotein.肝细胞癌患者的乙肝表面抗原血症与临床病程及甲胎蛋白的关系
Gastroenterology. 1977 Jun;72(6):1213-6.
2
Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.肝细胞癌的临床病理特征——乙肝血清学阳性与阴性患者的比较
Hepatogastroenterology. 1984 Apr;31(2):64-8.
3
Hepatitis B surface antigen and alpha-fetoprotein in patients with hepatocellular carcinoma.肝细胞癌患者的乙肝表面抗原和甲胎蛋白
Gastroenterology. 1978 Jan;74(1):163-4.
4
Primary hepatocellular carcinoma with hepatitis B virus infection in a 16-year-old noncirrhotic patient.一名16岁非肝硬化患者患乙型肝炎病毒感染相关的原发性肝细胞癌。
Am J Gastroenterol. 1983 May;78(5):305-8.
5
Distribution of five antigens in hepatocellular carcinoma.五种抗原在肝细胞癌中的分布。
Lab Invest. 1979 Aug;41(2):101-5.
6
Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.日本HBsAg和抗-HCV抗体均为阴性但抗-HBc抗体为阳性的肝细胞癌的临床特征
Am J Gastroenterol. 2002 Jan;97(1):156-61. doi: 10.1111/j.1572-0241.2002.05440.x.
7
Histocompatibility antigens in patients with hepatocellular carcinoma and their relationship to chronic hepatitis B virus infection in these patients.肝细胞癌患者的组织相容性抗原及其与这些患者慢性乙型肝炎病毒感染的关系。
Gastroenterology. 1979 Sep;77(3):537-9.
8
Hepatitis B antigen and alpha fetoprotein in the sera of patients with hepatocellular carcinoma.肝细胞癌患者血清中的乙肝抗原和甲胎蛋白。
Indian J Med Res. 1977 Jan;65(1):95-100.
9
[The occurrence and significance of the presence of alpha fetoprotein (AFP) and Australia antigen (HBsAg) in the serum of 392 patients with chronic disease and primary malignant neoplasms of the liver].[392例慢性疾病及原发性肝癌患者血清中甲胎蛋白(AFP)及澳大利亚抗原(HBsAg)的出现情况及意义]
Acta Med Iugosl. 1978;32(3):243-51.
10
Hepatitis B antigen, alpha-fetoglobulins and primary hepatocellular carcinoma in Ethiopia.埃塞俄比亚的乙肝抗原、甲胎蛋白与原发性肝细胞癌
J Trop Med Hyg. 1976 Oct;79(10):230-4.

引用本文的文献

1
Hepatitis B virus antigens in primary hepatic carcinoma: immunofluorescent techniques on fixed liver tissue.原发性肝癌中的乙肝病毒抗原:固定肝组织的免疫荧光技术
J Clin Pathol. 1978 Dec;31(12):1133-9. doi: 10.1136/jcp.31.12.1133.